Related Experiment Video
Updated: May 11, 2026
09:06
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNAs in myeloid malignancies.
Jane E A Gordon1, Justin J-L Wong, John E J Rasko
1Gene & Stem Cell Therapy Program, Centenary Institute, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
British Journal of Haematology
|May 18, 2013
Summary
MicroRNAs (miRNAs) are crucial in myeloid cancer development and progression. This review highlights their roles as biomarkers and therapeutic targets in these hematological malignancies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are integral to human cancer development.
- Hematological malignancies were the first cancers linked to abnormal miRNA expression, advancing our understanding of miRNA roles in cancer.
- Aberrant miRNA expression is a hallmark of various cancers, including myeloid malignancies.
Purpose of the Study:
- To review the evolving roles of miRNAs in the pathogenesis of myeloid malignancies.
- To highlight significant findings regarding miRNA involvement in these cancers.
- To underscore the potential of miRNAs as biomarkers and therapeutic targets in myeloid malignancies.
Main Methods:
- Literature review of scientific publications.
- Analysis of studies focusing on miRNA expression and function in myeloid malignancies.
- Synthesis of current knowledge on miRNA-driven pathogenesis and therapeutic strategies.
Main Results:
- miRNAs play diverse and critical roles in the development and progression of various myeloid malignancies.
- Specific miRNAs are identified as potential diagnostic and prognostic biomarkers.
- miRNAs present promising avenues for novel therapeutic interventions in myeloid cancers.
Conclusions:
- MicroRNAs are pivotal in the pathogenesis of myeloid malignancies.
- Targeting miRNAs offers a promising strategy for treating hematological cancers.
- Further research into miRNA mechanisms will refine their clinical application in oncology.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...